Earnings Call · Q3 FY2024·2024-11-04

Q3 24EPS +100.00%*·Rev n/aQ2 24EPS +100.00%*·Rev n/aQ1 24EPS -17.50%·Rev n/aQ4 23EPS -42.71%·Rev n/a⚠ consensus missing

MEDIFAST INC MED

Steven Zenker — Head of Investor Relations

Dan Chard — Chairman and Chief Executive Officer

Jim Maloney — Chief Financial Officer

+1.2%1d on move date+1.5% vs SPY3d+6.0%5d+3.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MED calls or request research access.

More MED calls Browse calls Request research access